Showing 3151-3160 of 19322 results for "".
Utility of Stereoelectroencephalography in the Treatment of Drug-Resistant Epilepsy
https://reachmd.com/diseases-diagnoses/epilepsy-seizures/utility-of-stereo-electroencephalography-in-the-treatment-of-drug-resistant-epilepsy/48919/Drug-resistant epilepsy, which affects about a third of people with epilepsy, can be effectively treated with epilepsy surgery, leading to seizure freedom in appropriately selected individuals.Weekly Check-Up | January 11th 2016
https://reachmd.com/programs/video-library/weekly-check-january-11th-2016/7866/Welcome to the Weekly Check-up on ReachMD for the week of January 11th, 2016. Check out this week's programs: Depression Among Resident Patients An In-Depth Discussion of Multiple Myeloma (CME) The Path to Lung Transplantation: Roles of Extracorporeal Membrane Oxygenation (ECMO) ImplemenEpilepsy Essentials: Hemispherectomy for Early-Onset Pediatric Epilepsy: A Big Surgery for Small People
https://reachmd.com/diseases-diagnoses/epilepsy-seizures/epilepsy-essentials-hemispherectomy-for-early-onset-pediatric-epilepsy-a-big-surgery-for-small-people/32031/Early hemispherectomy in children and adolescents with medication-refractory epilepsy can lead to improved seizure control, cognition, and development.Pharmacology of Emerging Selective Sodium Channel Antagonists for the Treatment of Epilepsy
https://reachmd.com/diseases-diagnoses/epilepsy-seizures/pharmacology-of-emerging-selective-sodium-channel-antagonists-for-the-treatment-of-epilepsy/39904/The development of isoform-selective sodium channel inhibitors that spare GABAergic interneuron function is in its early stages but holds promise as an exciting area of research.Expanding Treatment Options in PNH: Expert Approaches to Personalized Care
https://reachmd.com/programs/medical-industry-feature/pnh-expert-approaches-personalized-care/35651/Managing patients with paroxysmal nocturnal hemoglobinuria (PNH) is never a “one-size-fits-all” approach. With the emergence of a therapy like FABHALTA® (iptacopan), which delivers comprehensive control of intravascular and extravascular hemolysis, we have an option to offer to eligible adult patienMoving Beyond Hesitation: Exploring an Oral Option for Managing PNH
https://reachmd.com/programs/medical-industry-feature/oral-option-paroxysmal-nocturnal-hemoglobinuria/35649/It wasn’t that long ago that patients diagnosed with paroxysmal nocturnal hemoglobinuria (PNH) had limited treatment options;1 however, even with more options available, hesitancy to start therapy, particularly complement inhibition, still exists for some patients. As a result, knowing how to communThe Metabolic Roots of Early-Onset Colorectal Cancer
https://reachmd.com/programs/project-oncology/metabolic-roots-early-onset-crc/49166/The CellFX System from Pulse Biosciences
https://reachmd.com/topics/energy-based-devices/the-cellfx-system-from-pulse-biosciences/35181/Board Forum: Hope and Skepticism in the Aesthetics Pipeline
https://reachmd.com/topics/practice-development/board-forum-hope-and-skepticism-in-the-aesthetics-pipeline/35191/Critical Bilateral Carotid Artery Disease Presenting as Hemichorea
https://reachmd.com/programs/practical-neurology/critical-bilateral-carotid-artery-disease-presenting-as-hemichorea/32195/Vascular imaging can be an important test in the diagnostic workup of adult-onset hemichorea, even in the absence of structural brain lesions.